We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

227 hedge funds and large institutions have $2.31B invested in Ironwood Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 84 increasing their positions, 70 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $2.87M

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

20% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 70

9% more funds holding

Funds holding: 208 → 227 (+19)

1.17% more ownership

Funds ownership: 107.75% → 108.92% (+1.2%)

3% more capital invested

Capital invested by funds: $2.24B → $2.31B (+$69M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
227
Holders Change
+19
Holders Change %
+9.13%
% of All Funds
3.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
38
Increased
84
Reduced
70
Closed
17
Calls
$13.1M
Puts
$2.87M
Net Calls
+$10.3M
Net Calls Change
-$1.35M

Top Buyers

1
LSV Asset Management
LSV Asset Management
Illinois
+$44.6M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$25.9M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$24.8M
4
BlackRock
BlackRock
New York
+$11.9M
5
FP
Foundry Partners
Minnesota
+$11.5M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$46.4M
2
CCM
Camber Capital Management
Massachusetts
-$25.8M
3
BCM
Brown Capital Management
Maryland
-$19.1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$15.9M
5
BM
Bridger Management
New York
-$13.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of New Jersey Common Pension Fund D
76
State of New Jersey Common Pension Fund D
New Jersey
$2.65M -$60.3K -4,667 -2%
HVC
77
Healthcare Value Capital
New Jersey
$2.61M – – –
RhumbLine Advisers
78
RhumbLine Advisers
Massachusetts
$2.48M +$79.8K +6,173 +3%
Schroder Investment Management Group
79
Schroder Investment Management Group
United Kingdom
$2.4M – – –
Jennison Associates
80
Jennison Associates
New York
$2.31M +$789K +61,034 +53%
Macquarie Group
81
Macquarie Group
Australia
$2.23M +$2.16M +167,200 +4,412%
RIM
82
Redwood Investment Management
Arizona
$2.05M +$203K +15,720 +11%
Nomura Holdings
83
Nomura Holdings
Japan
$2.01M +$1.95M +151,000 New
BCB
84
Brian C. Broderick
$1.85M -$32.3K -2,500 -2%
ACM
85
AlphaCrest Capital Management
New York
$1.82M +$114K +8,834 +7%
Legal & General Group
86
Legal & General Group
United Kingdom
$1.8M +$388K +30,007 +28%
Russell Investments Group
87
Russell Investments Group
United Kingdom
$1.77M -$253K -19,612 -13%
APG Asset Management
88
APG Asset Management
Netherlands
$1.77M +$428K +33,100 +27%
SEI Investments
89
SEI Investments
Pennsylvania
$1.74M +$1.27M +98,150 +299%
First Trust Advisors
90
First Trust Advisors
Illinois
$1.67M +$1.66M +128,107 New
T. Rowe Price Associates
91
T. Rowe Price Associates
Maryland
$1.59M -$138K -10,700 -8%
AG
92
Artal Group
Luxembourg
$1.44M – – –
GAM
93
Gotham Asset Management
New York
$1.44M +$200K +15,440 +16%
GC
94
Globeflex Capital
California
$1.43M +$486K +37,625 +53%
JCIA
95
Jackson Creek Investment Advisors
Colorado
$1.31M +$10.4K +803 +0.8%
Citadel Advisors
96
Citadel Advisors
Florida
$1.2M -$1.03M -79,701 -46%
PAM
97
Panagora Asset Management
Massachusetts
$1.16M -$50.4K -3,898 -4%
Fisher Asset Management
98
Fisher Asset Management
Washington
$1.12M -$216K -16,706 -16%
Tudor Investment Corp
99
Tudor Investment Corp
Connecticut
$1.09M +$1.08M +83,672 New
AIG
100
American International Group
New York
$1.04M -$24.4K -1,889 -2%
2 3
4
5 6

IRWD Hedge Fund Activity: Q3 2021 in Review

227 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2021, worth a combined $2.31B — up 3.1% from $2.24B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IRWD positions and 17 closed out — a net gain of 21 holders — while 84 added to existing stakes and 70 trimmed.

The largest buyer was LSV Asset Management, adding an estimated $44.6M. The largest seller was Wellington Management Group, cutting an estimated $46.4M.

  • 227 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2021, up from 208 in Q2 2021.
  • Funds reported $2.31B of Ironwood Pharmaceuticals stock for Q3 2021, up 3.1% quarter-over-quarter.
  • 38 funds opened new Ironwood Pharmaceuticals positions in Q3 2021 and 17 closed out, a net change of +21 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2021 was LSV Asset Management, an estimated $44.6M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2021 was Wellington Management Group, an estimated $46.4M sold.

Based on aggregated 13F filings for Q3 2021.